A Phase II Study of Fulvestrant (Faslodex) in the Treatm

Project: Research project

Project Details

Description

A Phase II Study of Fulvestrant (Faslodex) in the Treatment of Recurrent Ovarian Carcinoma
StatusFinished
Effective start/end date12/1/0612/31/09

Funding

  • AstraZeneca